Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PMCB | INDP | AVTX | ||
| Company | Pharmacyte Biotech Inc | Indaptus Therapeutics Inc | Avalo Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.20 | 2.14 | 16.58 | ||
| High | 2.20 | 2.23 | 17.05 | ||
| Low | 2.12 | 2.14 | 16.01 | ||
| Last | 2.12 | 2.15 | 17.02 | ||
| Change | unch | +0.03 | +0.14 | ||
| % Change | unch | +1.42% | +0.83% | ||
| Volume | 3,572 | 4,480 | 24,859 | ||
| 20-Day Average Volume | 14,354 | 23,592 | 177,147 | ||
| Previous Close | 2.12 | 2.12 | 16.88 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.23 | 2.43 | 14.77 | ||
| 20-Day Raw Stochastic | 10.42% | 10.14% | 53.53% | ||
| 20-Day Relative Strength | 45.62% | 46.18% | 60.89% | ||
| Weighted Alpha | -27.47 | -19.29 | -90.57 | ||
| Today's Opinion | 48% Sell | 16% Buy | 24% Buy | ||
| Previous Opinion | 48% Sell | Hold | 24% Buy | ||
| Last Month's Opinion | 16% Buy | 40% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.47% since 04/23/24 | -14.06% since 04/23/24 | +25.53% since 04/23/24 | ||
| Low | 2.08 on 04/25/24 | 2.05 on 04/26/24 | 12.80 on 04/24/24 | ||
| High | 2.20 on 04/30/24 | 2.67 on 04/24/24 | 17.49 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -10.55% since 03/28/24 | -4.46% since 03/28/24 | -24.97% since 03/28/24 | ||
| Low | 2.07 on 04/18/24 | 2.05 on 04/26/24 | 11.10 on 04/09/24 | ||
| High | 2.55 on 04/04/24 | 2.95 on 04/15/24 | 22.47 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -5.78% since 01/30/24 | +28.14% since 01/30/24 | +231.02% since 01/30/24 | ||
| Low | 1.94 on 03/18/24 | 1.56 on 02/13/24 | 4.01 on 02/05/24 | ||
| High | 2.58 on 03/27/24 | 2.95 on 04/15/24 | 34.46 on 03/28/24 | ||
| 6-Month | |||||
| %Chg | +1.44% since 10/30/23 | -5.63% since 10/30/23 | -26.73% since 10/30/23 | ||
| Low | 1.92 on 11/20/23 | 1.56 on 02/13/24 | 3.95 on 01/17/24 | ||
| High | 2.58 on 03/27/24 | 3.25 on 11/06/23 | 34.46 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 17,921 | 18,118 | 17,456 | ||
| Shares Outstanding, K | 8,453 | 8,539 | 1,034 | ||
| Annual Sales | 0 | 0 | 1,920,000 | ||
| Annual Net Income | -4,320,000 | -15,420,000 | -31,540,000 | ||
| Last Quarter Sales | 0 | 0 | 570,000 | ||
| Last Quarter Net Income | -620,000 | -4,000,000 | -8,170,000 | ||
| 60-Month Beta | -0.18 | 1.28 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.65 on 03/18/24 | -0.47 on 03/13/24 | -26.19 on 11/09/23 | ||
| Latest Earnings Date | 03/21/24 | 05/09/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||